Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
For Additional Information about APL-2 visit http://www.apellis.com
APL-2 Study to Assess the Safety, Tolerability, efficacy and PK of APL-2 in patients with wAIHA or CAD. Phase 2 Trial ClinicalTrials.gov Identifier: NCT03226678 (Plaudit Study) Active, Not Recruiting Last Updated Post February 7, 2020 Estimated Study Completion Date December 2020
Copyright © 2022 Cold Agglutinin Disease Foundation - All Rights Reserved.
Contact Us: info@cadfadvocacy.org
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.